4//SEC Filing
Ryweck Daniel E. 4
Accession 0001213900-25-047913
CIK 0001514183other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 7:02 PM ET
Size
5.7 KB
Accession
0001213900-25-047913
Insider Transaction Report
Form 4
Ryweck Daniel E.
Chief Financial Officer
Transactions
- Award
Options (right to buy)
2025-05-23+50,000→ 55,000 totalExercise: $0.43From: 2026-05-23Exp: 2035-05-23→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant.
Documents
Issuer
Silo Pharma, Inc.
CIK 0001514183
Entity typeother
Related Parties
1- filerCIK 0001652799
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 7:02 PM ET
- Size
- 5.7 KB